
High-performance liquid chromatography (HPLC) confirms safe blood levels of slow-release bupivacaine nanoparticles.
SEC-MALS identifies monomers, dimers, hexamers, and higher aggregates of insulin to determine optimal formulation, storage, and administration conditions.





